Steven Gillis - 18 Mar 2026 Form 3 Insider Report for TAKEDA PHARMACEUTICAL CO LTD (TAK)

Reporting relationship
Director
Issuer ticker
TAK
Reported as of
18 Mar 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3
Accepted by SEC
18 Mar 2026, 06:09:49 UTC
Prior SEC filing
28 Jul 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Max Heuer, by power of attorney, for Steven Gillis

Key filing fact

Steven Gillis filed Form 3 for TAKEDA PHARMACEUTICAL CO LTD (TAK) on 18 Mar 2026.

Key facts

  • This page summarizes Steven Gillis's Form 3 filing for TAKEDA PHARMACEUTICAL CO LTD (TAK).
  • 0 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 18 Mar 2026, 06:09.

Change

  • Previous filing in this sequence was filed on 28 Jul 2023.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reporting Owners (1)

CIK 0001229592 Primary reporting owner

GILLIS STEVEN

Relationship
Director
Address
8755 W. HIGGINS ROAD, SUITE 1025, CHICAGO
Signature
/s/ Max Heuer, by power of attorney, for Steven Gillis
Signature date
18 Mar 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

TAK holding

Ordinary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
9,700
Date
18 Mar 2026
Ownership
Direct
Footnotes
F1
TAK holding

American Depositary Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
15,857
Date
18 Mar 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TAK holding Derivative

Tax Obligation Award

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
1,152
Exercise price
Footnotes
F2
TAK holding Derivative

Tax Obligation Award

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
1,192
Exercise price
Footnotes
F2
TAK holding Derivative

Tax Obligation Award

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
1,180
Exercise price
Footnotes
F2
TAK holding Derivative

Cash Settled Retirement Award

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
18 Mar 2026
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
2,356
Exercise price
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on the following schedule: June 1, 2026 (3,100 ordinary shares), June 1, 2027 (3,400 ordinary shares) and June 1, 2028 (3,200 ordinary shares).

Footnote F2

Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.

Footnote F3

Represents an award of restricted stock units (RSUs). Each RSU represents a contingent right to receive a cash amount equivalent to the value of one Ordinary Share at the time of vest. The RSUs vest upon the director's retirement from the board.

SEC remarks

Exhibit 24 Power of Attorney

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .